Division of Cardiac Surgery, Ospedale Policlinico San Martino, Genoa, Italy.
Department of Integrated Sciences (DISC), University of Genova, Genova, Italy.
Cardiovasc Intervent Radiol. 2021 Nov;44(11):1709-1719. doi: 10.1007/s00270-021-02893-3. Epub 2021 Jun 25.
Ruptured descending thoracic aorta (rDTA) is an harmful condition requiring emergent treatment. Thoracic endovascular aortic repair (TEVAR) is replacing the traditional open repair in the majority of descending thoracic aortic disease. An unanimous agreement regarding the optimal approach to treat rDTA has not been reached yet due to the lack of evidences supporting the improvement of long-term survival. The present meta-analysis of observational cohort studies aims to estimate the outcome of endovascular (TEVAR) versus surgical (OR) approach in the treatment of rDTA.
Prisma Statement for performing and reporting meta-analysis has been used. MEDLINE, Scopus and the Cochrane Library databases were searched. A meta-analysis of observational cohort studies that examined the outcomes after OR and TEVAR for the management of rDTA was performed.
A total of 10,466 patients with rDTA were screened. Endovascular therapy was associated with a lower risk of in-hospital mortality compared with open repair (Risk Ratio[RR] 0.63; 95% CI0.57-0.70). The risk of stroke rate was not statistically different between endovascular versus open approach (RR0.86; 95% CI0.62-1.19). Endovascular treatment had benefits on paraplegia (RR0.70; 95% CI0.55-0.91) and other neurological complications (RR0.24; 95% CI0.10-0.56). TEVAR was associated with lower renal failure, cardiac complications and vascular injuries. Late mortality (Hazard Ratio[HR] 0.84; 95% CI0.63-1.13) and re-intervention rate (RR1.48; 95% CI0.80-2.74) were not significantly different between TEVAR and OR.
TEVAR seems to offer advantages in terms of early mortality and complications rate. Moreover, data on late mortality and re-intervention are encouraging to consider endovascular treatment comparable to open repair for acute thoracic aorta emergency on long-term follow-up.
降主动脉夹层破裂(rDTA)是一种需要紧急治疗的有害情况。胸主动脉腔内修复术(TEVAR)在大多数降主动脉疾病中取代了传统的开放修复。由于缺乏证据支持长期生存的改善,尚未就治疗 rDTA 的最佳方法达成一致意见。本项观察性队列研究的荟萃分析旨在评估血管内(TEVAR)与手术(OR)方法在 rDTA 治疗中的结果。
采用了 PRISMA 声明进行和报告荟萃分析。检索了 MEDLINE、Scopus 和 Cochrane 图书馆数据库。对 OR 和 TEVAR 治疗 rDTA 管理后结局的观察性队列研究进行了荟萃分析。
共筛选出 10466 例 rDTA 患者。与开放修复相比,血管内治疗的院内死亡率风险较低(风险比[RR]0.63;95%置信区间 0.57-0.70)。血管内与开放方法之间的卒中发生率风险无统计学差异(RR0.86;95%置信区间 0.62-1.19)。血管内治疗对截瘫(RR0.70;95%置信区间 0.55-0.91)和其他神经并发症(RR0.24;95%置信区间 0.10-0.56)有获益。TEVAR 与较低的肾衰竭、心脏并发症和血管损伤相关。晚期死亡率(风险比[HR]0.84;95%置信区间 0.63-1.13)和再干预率(RR1.48;95%置信区间 0.80-2.74)在 TEVAR 和 OR 之间无显著差异。
TEVAR 在早期死亡率和并发症发生率方面似乎具有优势。此外,关于晚期死亡率和再干预的数据令人鼓舞,认为在长期随访中,血管内治疗与开放修复相比,可用于治疗急性胸主动脉急症。